Home » About the AACR » Newsroom » Archives for 2022 »
NEW ORLEANS – During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income...
NEW ORLEANS – In its first year of implementation, the RACE Act has resulted in increased requirements for more...
NEW ORLEANS – A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent...
An mRNA vaccine was combined with CAR T cells that target tumor cells expressing the CLDN6 antigen NEW ORLEANS...
Two-year follow up of the CodeBreaK 100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile NEW...
Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment NEW ORLEANS – More than...
NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified...
Five new members elected to the Board of Directors and four new members elected to the Nominating Committee PHILADELPHIA...